Kenvue Inc. (KVUE) closed Tuesday at $19.30, a gain of 2.28% for the session. The consumer health company carried a market capitalization of $36.24 billion as of October 21, 2026.
The single-day advance extended a broader rally for the stock. Over the past seven days, shares have risen 8.67%, and the 30-day gain stands at 8.31%, reflecting sustained buying interest across recent weeks.
The consistency of the move across the 7-day and 30-day windows suggests the session's advance is part of a longer trend rather than an isolated spike. Kenvue, which was spun off from Johnson & Johnson, operates across consumer health brands in categories including skin health, self care, and essential health.
No corporate announcements were cited in the data provided for Tuesday's session. The price and percentage changes reflect market activity through the close of October 21, 2026.
